English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52812046    線上人數 :  676
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"lai kp"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 11-17 / 17 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2005-12 Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-kappaB pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Chou, CH; Wei, LH; Kuo, ML; Huang, YJ; Lai, KP; Chen, CA; Hsieh, CY.
國立臺灣大學 2005-12 A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Su, JL; Lai, KP; Chen, CA; Yang, CY; Chen, PS; Chang, CC; Chou, CH; Hu, CL; Kuo, ML; Hsieh, CY; Wei, LH.
國立臺灣大學 2005-06 A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Su, JL; Lai, KP; Chen, CA; Yang, CY; Chen, PS; Chang, CC; Chou, CH; Hu, CL; Kuo, ML; Hsieh, CY; Wei, LH
國立臺灣大學 2005-01 Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Wei, LH; Lai, KP; Chen, CA; Cheng, CH; Huang, YJ; Chou, CH; Kuo, ML; Hsieh, CY
國立臺灣大學 2005-01 Up-regulation of interleukin-6 in human ovarian cancer cell via a Gi/PI3K-Akt/NF-{kappa}B pathway by lysophosphatidic acid, an ovarian cancer-activating factor. Chou, CH; Wei, LH; Kuo, ML; Huang, YJ; Lai, KP; Chen, CA; Hsieh, CY
國立臺灣大學 2005-01 Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. Wei, LH; Lai, KP; Chen, CA; Cheng, CH; Huang, YJ; Chou, CH; Kuo, ML; Hsieh, CY
國立臺灣大學 2004-12 Overexpression of Her-2/NEU in epithelial ovarian carcinoma induces vascular endothelial growth factor C by activating Nf-kappa B: implications for malignant ascites formation and tumor lymphangiogenesis. Hsieh, CY; Chen, CA; Chou, CH; Lai, KP; Jeng, YM; Kuo, ML; Wei, LH

顯示項目 11-17 / 17 (共1頁)
1 
每頁顯示[10|25|50]項目